This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Bernik, M. A. Articles by Gentil, V. Search for Related Content PubMed Articles by Bernik, M. A. Articles by Gentil, V. Social Bookmarking                         What's this?

Flumazenil-precipitated withdrawal symptoms in chronic users of therapeutic doses of diazepam

Instituto de Psiquiatria, Hospital das Clinicas, Faculdade de Medicina

Clarice Gorenstein

Departamento de Farmacologia, Instituto de Ciências Biomédicas

Valentim Gentil

Departamento de Psiquiatria, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil

A prototype benzodiazepine (BDZ) antagonist, flumazenil (1 mg, i.v.) or placebo was administered to eight chronic users (5-15 years) of therapeutic doses of diazepam (10-25 mg/d), in a double-blind, placebo-controlled design in order to evaluate the presence of physiological dependence. The three patients receiving flumazenil developed anxiety reactions, with significant increases in bodily and psychological symptoms, as measured by rating scales. In two these amounted to a panic attack. Subjects on placebo tended to show decreases in measures of anxiety. The severity of precipitated reactions was not related to the total cumulative exposure to diazepam, but to a history of panic attacks. Previous panic may increase the vulnerability to severe reactions to flumazenil.

Journal of Psychopharmacology, Vol. 5, No. 3, 215-219 (1991)
DOI: 10.1177/026988119100500306


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				P.E. Harrison-Read, P. Tyrer, C. Lawson, S. Lack, C. Fernandes, and S.E. File Flumazenil-precipitated panic and dysphoria in patients dependent on benzodiazepines: a possible aid to abstinence J Psychopharmacol, January 1, 1996; 10(2): 89 - 97. [Abstract] [PDF]

				M. H. Lader Commentary on 'Flumazenil-precipitated panic and dysphoria in patients dependent on benzodiazpines: a possible aid to abstinence' J Psychopharmacol, January 1, 1996; 10(2): 98 - 98. [PDF]

				P.E. Harrison-Read, P. Tyrer, C. Lawson, S. Lack, C. Fernandes, and S.E. File Flumazenil-precipitated panic and dysphoria in patients dependent on benzodiazepines: a possible aid to abstinence--authors' response J Psychopharmacol, January 1, 1996; 10(2): 99 - 100. [PDF]

				M. H. Lader and S. V. Morton A pilot study of the effects of flumazenil on symptoms persisting after benzodiazepine withdrawal J Psychopharmacol, January 1, 1992; 6(3): 357 - 363. [Abstract] [PDF]